First Horizon Corporation’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.1K Buy
1,190
+145
+14% +$9.89K ﹤0.01% 548
2026
Q1
$67.5K Sell
1,045
-178
-15% -$12.5K ﹤0.01% 562
2025
Q4
$82.3K Buy
1,223
+453
+59% +$30.5K ﹤0.01% 553
2025
Q3
$56.5K Buy
+770
New +$51.1K ﹤0.01% 598

Other funds holding HALO

First Horizon Corporation's HALO Position: Q2 2026 in Review

First Horizon Corporation increased its Halozyme (HALO) stake by 14% in Q2 2026, buying an estimated $9.89K and bringing the position to 1,190 shares worth $93.1K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

First Horizon Corporation first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. 248 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • First Horizon Corporation held 1,190 shares of Halozyme worth $93.1K as of Q2 2026.
  • First Horizon Corporation bought 145 Halozyme shares in Q2 2026, an estimated $9.89K.
  • Halozyme made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #548 holding.
  • First Horizon Corporation first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • 248 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.